Noven Therapeutics (Lithobid) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Noven Therapeutics (Lithobid) General Information

Description

Lithium carbonate extended release tablets. It contains 300 milligram of lithium carbonate which helps in treatment of manic episodes of bipolar disorder.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • 11960 South West 144th Street
  • Miami, FL 33186
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Noven Therapeutics (Lithobid) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Noven Therapeutics (Lithobid)‘s full profile, request access.

Request a free trial

Noven Therapeutics (Lithobid) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Noven Therapeutics (Lithobid)‘s full profile, request access.

Request a free trial